This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (12) Citing Articles via Google Scholar Google Scholar Articles by Ingelsson, E. Articles by Lind, L. Search for Related Content PubMed PubMed Citation Articles by Ingelsson, E. Articles by Lind, L.

Inflammation, as Measured by the Erythrocyte Sedimentation Rate, Is an Independent Predictor for the Development of Heart Failure

Erik Ingelsson, MD^_*,_*, Johan Ärnlöv, MD, PhD^_*, Johan Sundström, MD, PhD^_* and Lars Lind, MD, PhD^,

^_* Public Health and Caring Sciences, Uppsala, Sweden
Medical Sciences, Uppsala University, Uppsala, Sweden
Astra Zeneca R & D, Mölndal, Sweden

View larger version (16K): [in a new window]   Figure 1 Incidence rates of congestive heart failure (CHF) by quartiles (quartile 1, erythrocyte sedimentation rate [ESR] = 1 to 3 mm/h; quartile 2, 4 to 6 mm/h; quartile 3, 7 to 10 mm/h; quartile 4, 11 to 83 mm/h) of ESR. Lines indicate 95% confidence intervals.

View larger version (17K): [in a new window]   Figure 2 Nelson-Aalen plot of cumulative incidence of heart failure in the cohort free from heart failure, myocardial infarction, and valvular disease at baseline by two groups (greater than vs. less than or equal to the median [erythrocyte sedimentation rate (ESR) 6 mm/h]) of ESR.